ITCI

Intra-Cellular Therapies, Inc.

About ITCI

Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company provides CAPLYTA (lumateperone) for the treatment of schizophrenia in adults. The CAPLYTA is a prescription medicine used to treat the depressive episodes in adults with bipolar I or II, that can be taken alone or with lithium or valproate. The Company's pipeline is focused on three platforms: lumateperone and follow-on compounds, a phosphodiesterase 1 (PDE1) inhibitor platform and discovery platform which includes ITI-333 a novel compound with high affinity at serotonin 5-HT2A, dopamine D1 and mu opioid (MOP) receptors. The Company’s subsidiaries are ITI, Inc. (ITI) and ITI Limited.

Buy US stocks in Australia starting with ITCI. Open an account and start investing today!

Market Capitalisation

$4.52B

Price-earnings ratio

Dividend yield

0.00%

Volume

583.39K

High today

$49.30

Low today

$47.74

Open price

$48.51

52-week high

$66.00

52-week low

$42.42

ITCI FAQs

How much is one share of Intra-Cellular Therapies, Inc.?

One share of Intra-Cellular Therapies, Inc. is valued at $47.89.

What is the ticker symbol for Intra-Cellular Therapies, Inc.?

The ticker symbol for Intra-Cellular Therapies, Inc. is ITCI.

How do I buy ITCI shares in Australia?

To buy ITCI stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in ITCI

What is the market capitalisation of Intra-Cellular Therapies, Inc. ITCI?

As of 30/01/2023 Intra-Cellular Therapies, Inc. has a market cap of $4.5B.

What is the 52-week high for Intra-Cellular Therapies, Inc. stock?

The Intra-Cellular Therapies, Inc. 52-week high stock price is $66.00.

What is the 52-week low for Intra-Cellular Therapies, Inc. stock?

The Intra-Cellular Therapies, Inc. 52-week low stock price is $42.42.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.